(NewsDirect)
By Meg Flippin, Benzinga
Vitamins may not be amiracle cure, but combined with exercise and a healthy diet, they havethe potential to greatly improve health and wellness. It’s no wondervitamin supplements are a multi-billion dollar business, projected tohit a market size of $98billion in less than a decade. While vitamin supplements havebeen around since the early 1900s, it wasn’t until the late 1950sthat they took off with the masses as consumers adopted healthierlifestyles and awareness grew about their benefits.
Today, there arevitamins for everything from improving gut health to slowing aging. Asurvey conducted in 2019 found that more than fourin five Americans take vitamins or supplements .
The regenerative wellness sector may befollowing a similar trajectory, where stem cells are playing a leadingrole in wellness and anti-aging thanks to their self-renewal ability.Stem cells have the potential to regeneratecells, tissues and organs in the body, improving people’squality of life and slowing the aging process. Studies have shown themore stem cells you have circulating in your blood, the greater theability of your body to renew itself – naturally.
Stem CellsTurn Back The Clock
Stem cells’ rejuvenating abilities are already making it abig business, one that seems poised for more growth in the years tocome, following in the footsteps of the vitamin industry. The stemcell market is projected to hit $32billion by 2030 , growing at a CAGR of 11.57%. That compares tothe global vitamin supplements market which reached$47.9 billion in 2021 and is projected to hit $98.6 billion by2031, growing at a CAGR of 7.6%. In its early days, the vitaminsupplements market had double-digit growth, similar to what the stemcell market is seeing.
One company planning to ride this burgeoning trend is Stemtech Corporation (OTCQB: STEK), the Naples, Florida company that develops science-based products to support wellness using thebody’s own stem cells. Stemtech says its stem cell enhancers improvethe body’s natural defense, renewal, rejuvenation and anti-agingprocesses. Its products also boast powerful anti-aging components,which is proving popular with its many loyal customers. The companyreports that sales are steadily increasing quarter over quarter andmore of the same is expected in 2024. That growth is being driven bydemand for its products and its network of distributors known asIndependent business Partners (IBPs) eager to sell Stemtech’s stemcell-based supplements. "Stemtech is witnessing the increase inthe number of our IBP Independent Business Partners network. Thispositive momentum is a testament to the appeal of Stemtech'sexceptional anti-aging products and the promising income-earningopportunity we offer," Stemtech President and COO John W. Meyersaid ina recent press release .
Stemtech isn’t the only player in the stem cell market,several transformative health companies are going after differentareas including Sprouts Farmers Market (NASDAQ: SFM), Amphastar Pharmaceuticals (NASDAQ: AMPH), OPKO HealthInc. (NASDAQ: OPK), Herbalife Ltd. (NASDAQ: HLF), Natural Grocers by Vitamin Cottage Inc. (NGVC), Nature'sSunshine Products Inc. (NASDAQ: NATR) and Henry Schein Inc. (NASDAQ: HSIC).
Stemtech’s Edge
Thanks to the science its approach is basedon, Stemtech believes it has an edge over other players in the stemcell enhancing market. Stemrelease3™, Stemtech’s most advancedstem cell nutrition product, contains stemrelease3, a blend ofclinically tested ingredients that Stemtech says help release millionsof your body’s own stem cells from the bone marrow into thebloodstream. The company says stemrelease3 also helps support telomerehealth, which is a potent defense to the aging process.
The RCM System, itsflagship system, is comprised of three products:Stemrelease3™, StemFlo Advanced® and MigraStem™ also containingsuperfood extracts, antioxidants, polysaccharides, vitamins, mineralsand other natural compounds. These are designed to support the healthyactivity of our stem cells and boost the immune and circulatory systemfunctions. The nutrients in RCM also help to activate the energyprocesses in the mitochondria, have antioxidant and detoxificationeffects and support telomere health, according to Stemtech.
Stemtech’s CellectOne™ Rapid Renew Stem Cell Peptide Night Cream is anotherproduct the company reports is popular. It uses patented ingredientQXP from Red Oak Bark to lower the skin's barriers so stem cellsand peptides containing antioxidants and proteins can penetrate deeperinto the skin, assisting in improving skin moisture, elasticity and amore youthful look.
The company also offers OraStem®, an all-natural toothpastethat protects, strengthens, rejuvenates, restores and supports yourteeth and gum function from the cellular level. In addition, Stemtechsays it also provides anti-oxidative and anti-microbial protection,supports your tooth strength with essential minerals, helps to gentlyremove stains, brightens your teeth in a natural and non-abrasive wayand freshens breath.
Stemtech’s line of supplements, skin care products and oralcare products aims to answer a need among consumers for anti-aging andwellness products that actually work. What vitamins did for healthyliving, stem cells can do for aging. Stemtech is planning to takecenter stage in this evolution, betting it can play a big role inrejuvenating the body and turning back the clock one stem cell at atime.
Stem cell nutrition, ‘stemceuticals’, skincare,network marketing, anti-aging, longevity, all-natural, plant-basedproducts; nutritional supplements
This post containssponsored content. This content is for informational purposes only andnot intended to be investing advice.
Disclaimer: Thisannouncement contains forward-looking statements within the meaning ofthe “safe harbor” provisions of the U.S. Private SecuritiesLitigation Reform Act of 1995. Such statements include but are notlimited to statements identified by words such as "believes,""expects," "anticipates," "estimates,""intends," "plans," "targets,""projects" and similar expressions. The statements in thisrelease are based upon the current beliefs and expectations of ourcompany's management and are subject to significant risks anduncertainties. Actual results may differ from those set forth in theforward-looking statements. Numerous factors could cause or contributeto such differences, including, but not limited to, results ofclinical trials and/or other studies, the challenges inherent in newproduct development initiatives, the effect of any competitiveproducts, our ability to license and protect our intellectualproperty, our ability to raise additional capital in the future thatis necessary to maintain our business, changes in government policyand/or regulation, potential litigation by or against us, anygovernmental review of our products or practices, as well as otherrisks discussed from time to time in our filings with the Securitiesand Exchange Commission, including, without limitation, our latest10-Q Report filed on December 1, 2023. We undertake no duty to updateany forward-looking statement, or any information contained in thispress release or in other public disclosures at any time. Finally, theinvesting public is reminded that the only announcements orinformation about Stemtech Corporation which are condoned by theCompany must emanate from the Company itself and bear our name as itsSource.
Contact Details
GabrielRodriguez
CompanyWebsite
Copyright (c) 2024 TheNewswire - All rights reserved.